Testing Shorter Radiation Therapy for High-Risk Prostate Cancer
Phase 3
1,209
about 12 years
18+
Male only
388 sites in AL, AR, CA +39
What this study is about
This trial is testing whether shorter duration radiation therapy, using a higher dose per treatment over two weeks, can prevent prostate cancer from returning as well as the usual longer duration radiation therapy (20 to 45 treatments over 4 to 9 weeks). It involves collecting biospecimens and imaging scans to assess the effectiveness of this new approach.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Quality-of-Life Assessment
- 2.Questionnaire Administration
- 3.Receive External Beam Radiation Therapy
- +3 more
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You are randomly assigned, but you will know your treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Secondary: Fatigue, Incidence of adverse events (AEs), Overall survival
diagnostic, imaging, radiation
Oncology